ADVERTISEMENT

Alembic Pharma Gets Regulator's Approval To Market Antidepressant Drug In US

Brexpiprazole tablets are indicated as an adjunctive therapy to antidepressants. (File)
Brexpiprazole tablets are indicated as an adjunctive therapy to antidepressants. (File)
Alembic Pharmaceuticals today said it has received an approval from the US health regulator to market a generic antidepressant medication in the American market.
Register for Free
to continue reading
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit